Issue 3 2024
-
Cancer Immunotherapy Experts Will Share Insights on Immune-Related Toxicities
The potential of innovative cancer therapies, especially chimeric antigen receptor T-cell (CAR-T) therapies, is being explored for treating patients with autoimmune diseases. Marco Ruella, MD, will provide an overview of CAR-T production and therapeutic use.
-
Session to Address Health Disparities and Other Challenges to Clinical Trial Design
Studies have shown that the main reason why people from historically marginalized communities haven’t participated in clinical trials is that no one asked them, said one of the featured speakers, Janet Pope, MD, FRCPC, MPH.
-
Educators to Offer Instruction on Maximizing the Effectiveness of Questions, Technology as Teaching Tools
Questions can be more effective for learners than reading or taking notes, in part because the act of retrieval makes that information more readily available in the future, as Jonathan Hausmann, MD, will explain in this session.
-
Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
Christian Pagnoux, MD, MSc, MPH
